Mission: To be one of the most innovative healthcare companies in the world where passionate people deliver breakthrough evidence-based therapies that transform patient lives.
Nevro is committed to improving outcomes in Chronic Pain and people are taking notice! We are excited to share that the publication of our 24-month RCT outcomes earned Top Pain Paper of the Year from the prestigious journal - Neurosurgery.
Our leader Rami Elghandour and CFO Andrew Galligan share Nevro's positive outlook at the Morgan Stanley 2017 Global Healthcare Conference
Learn how Nevro is impacting patients’ lives
Learn more about Nevro
“All qualified applicants will receive consideration for employmentwithout regard to race, sex, color, religion, sexual orientation, gender identity,national origin, protected veteran status, or on the basis of disability.”
RAMI ELGHANDOUR — PRESIDENT AND CEO
Rami Elghandour joined Nevro in 2012, has served as Nevro’s Chief Business Officer, and currently serves as President and CEO of the company. Prior to joining Nevro, Mr. Elghandour was an investor with Johnson & Johnson Development Corporation (JJDC), where he led several investments including Nevro Series B Financing. During his tenure, Mr. Elghandour served on the Board of Directors of several private companies, including Nevro’s, and led strategic initiatives in the development and management of JJDC’s portfolio. Prior to joining JJDC, Mr. Elghandour worked for Advanced Neuromodulation Systems, Inc. (acquired by St. Jude Medical, Inc.), where he led firmware design and development on several implantable spinal cord stimulators. Mr. Elghandour received a MBA from the Wharton School of the University of Pennsylvania and holds a BS in Electrical and Computer Engineering from Rutgers University School of Engineering.
ANDREW GALLIGAN — CHIEF FINANCIAL OFFICER
Andrew Galligan joined Nevro in 2010 and is Vice President of Finance and Chief Financial Officer of the Company. Prior to joining Nevro, Mr. Galligan held the same position at OOMA, a consumer electronics manufacturer and VOIP service provider. Prior to that, Mr. Galligan was Vice President Finance and Chief Financial Officer of Reliant Technologies, a pioneer of fractional resurfacing skin treatments with aesthetic lasers. Mr. Galligan has also held the top financial executive position at several other medical device companies bringing to Nevro many years of experience in the commercialization of innovative medical therapeutic and diagnostic technologies. Mr. Galligan began his career in various financial positions at KPMG, and Raychem. Mr. Galligan received his degree in Business Studies from Trinity College in Dublin, Ireland, and he is also a Fellow of the Institute of Chartered Accountants in Ireland.
DAVID CARAWAY, MD, PHD — CHIEF MEDICAL OFFICER
David Caraway, MD, PhD joined Nevro in 2014 and serves as Nevro’s Chief Medical Officer. Prior to joining Nevro, Dr. Caraway was the CEO of The Center for Pain Relief, Tri-State, L.L.C., in partnership with St. Mary’s Regional Medical Center in Huntington, West Virginia. Dr. Caraway has maintained an active medical practice for over 20 years and has held leadership positions in the North American Neuromodulation and the American Society of Interventional Pain Physicians. As a nationally recognized expert in the treatment of chronic pain, he has lectured regionally, nationally, and internationally in the field of Interventional Pain Medicine and authored numerous publications in this field. Dr. Caraway received a BS in Chemical Engineering from the University of Virginia School of Engineering, an MD from the University of Virginia School of Medicine, and a PhD in Biophysics from the University of Virginia Graduate School of Arts and Sciences. He also received post-graduate training in Anesthesiology and Pain Management from the University of Virginia. Dr. Caraway is board certified by the American Board of Anesthesiology.
DOUG ALLEAVITCH — VICE PRESIDENT, QUALITY
Doug Alleavitch joined Nevro in 2015 and serves as Vice President, Quality of the company. Prior to joining the Company and since October 2009, Mr. Alleavitch served as Vice President, Operations and Quality Assurance at AEGEA Medical, Inc., a medical device company, where he oversaw manufacturing and quality assurance procedures. From February 2002-09, he held leadership positions at AngioScore, Inc., and Boston Scientific. Mr. Alleavitch received a BS in Chemical Engineering from Cornell University, an MS in Industrial Engineering, and an MBA from the University of Illinois, and an MS in Chemical Engineering from the Illinois Institute of Technology.
RICHARD B. CARTER — VICE PRESIDENT, FINANCE, CORPORATE CONTROLLER
Richard B. Carter joined Nevro in 2014 and serves as Vice President of Finance, Corporate Controller of the company. He has held roles of increasing responsibility in finance and accounting since joining Nevro as Corporate Controller in September 2014. From October 2013-14, Mr. Carter served as Corporate Controller at ClearEdge Power, Inc., a privately held fuel cell manufacturing company. Previously, Mr. Carter held financial leadership roles at Kovio, MiaSolé, PortalPlayer, and Transmeta Corporation. Mr. Carter received a B.S. in Business Administration from California State University, Chico. Mr. Carter is a Certified Public Accountant and began his career as an auditor at Ernst & Young, LLP.
CHRISTOFER CHRISTOFOROU — VICE PRESIDENT, RESEARCH AND DEVELOPMENT
Christofer Christoforou joined Nevro in 2016 and serves as Vice President, R&D. Prior to joining Nevro, Mr. Christoforou served as Vice President, Quality Engineering at Thoratec Corporation, a medical device company where he oversaw the operational, design and supplier quality engineering functions. From October 1999-14, Mr. Christoforou served in several leadership positions of increasing levels of responsibility at Thoratec Corporation. From April 1993-99, Mr. Christoforou served as a Manager of Engineering and various Engineering positions for United States Surgical Corporation, a producer of tools for use in surgery. Mr. Christoforou received a BS in Biomedical Engineering from Boston University and a MS in Biomedical Engineering from Johns Hopkins University in Maryland.
Nevro is committed to creating an open and inclusive culture. We welcome a diversity of thought brought to us from our team members, partners, and patients from differing genders, races, ages, religions, sexual orientations, education, and life experiences.
We were honored to host a Women in Neuromodulation event. The stories and experiences shared were truly inspiring. Thank you to everyone who made the event great, especially our physician partners, Dr. Julie Pilitsis, Dr. Jorden Tate, Dr. Jessica Jameson and Dr. Melanie Rosenblatt for sharing your experience and excellent outcomes with the group.
Nevro has been recognized as a winner of the 2018 Bay Area Best Places To Work, an innovative awards program presented by the San Francisco Business Times and the Silicon Valley Business Journal.
About 2018 Bay Area Best Places To Work
Best Places To Work is an innovative publication and awards program produced by the San Francisco Business Times and the Silicon Valley Business Journal.
Companies were evaluated and ranked across 5 categories based on how team members rated them as the highest on values such as fun, collaborative culture, solid compensation and benefits offerings and other amenities as well as management practices.
To be one of the most innovative healthcare companies in the world where passionate people deliver breakthrough evidence-based therapies that transform patient lives.
Teamwork - We mindset, willing to help others without any direct benefit
Integrity - All actions are transparent and ethical, strong sense of accountability
Grit - Willing to work hard, resilient during challenges
Passion - Patient and customer centric, outcomes oriented, positive role model for peers
Founder's Mentality - Continuous improvement, strong sense of ownership in the company and culture, solution oriented, customer obsessed, challenge the status quo
I have been working at Nevro full-time (More than 8 years)
Team: Nevro continues to hire people who are committed to helping move the company forward.
Cross-functional approach: We accomplish more by soliciting ideas across the board. We divide the workload, we are agile, and we trust each other.
Culture: We are a growing company and we maintain the core identity of our culture as we scale the company while redefining the messaging as necessary.
As we are growing, we also need to have space to spread out. Management is addressing this but things are tight at the moment. Looking forward to our new space.
Advice to Management
Continue to allow people to be passionate. Creativity exists on all teams - even the teams where the processes can be tedious. Continue to listen to the small voices and allow people to define their roles.
The process took 4 weeks. I interviewed at Nevro.
Nevro has a very long interview process and too many people interviewed and asked same questions. You meet with HR, department heads, team members and then CEO. I took another job offer while waiting for their offer.